555TiP A first-in-human trial of the integrin beta-6-targeted antibody–drug conjugate, SGN-B6A, in patients with advanced solid tumors
暂无分享,去创建一个
A. Patnaik | S. Piha-Paul | A. Dowlati | F. Braiteh | A. Hollebecque | R. Sanborn | K. Sehgal | S. Peters | B. Bockorny | J. López | E. Calvo | P. Zhou | V. Galvao | N. Nazarenko